Marika Ruponen
University Lecturer
I am a labmanager in the ocular drug delivery group lead by professor Arto Urtti. In addition, I act as a teacher in the school of pharmacy. My expertice areas are nanomedicines and biopharmacy.
School of Pharmacy, Faculty of Health Sciences
marika.ruponen@uef.fi | +358 40 355 2405
Research groups
Publications
112 items-
Comparison of barrier properties of outer blood-retinal barrier models - Human stem cell-based models as a novel tool for ocular drug discovery
Hellinen, Laura; Hongisto, Heidi; Ramsay, Eva; Kaarniranta, Kai; Vellonen, Kati-Sisko; Skottman, Heli; Ruponen, Marika. 2023. European journal of pharmaceutics and biopharmaceutics. 184: 181-188 -
Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration
Lombardo, Rosamaria; Ruponen, Marika; Rautio, Jarkko; Ghelardini, Carla; Di Cesare Mannelli, Lorenzo; Calosi, Laura; Bani, Daniele; Lampinen, Riikka; Kanninen, Katja M.; Koivisto, Anne M; Penttilä, Elina; Löppönen, Heikki; Pignatello, Rosario. 2023. Pharmaceutics. 15: -
Early-Stage Development of an Anti-Evaporative Liposomal Formulation for the Potential Treatment of Dry Eyes
Jantti, Janika; Viitaja, Tuomo; Sevon, Julia; Lajunen, Tatu; Raitanen, Jan-Erik; Schlegel, Cordula; Viljanen, Mira; Paananen, Riku O; Moilanen, Jukka; Ruponen, Marika; Ekholm, Filip. S. 2023. ACS pharmacology & translational science. 6: 1518-1530 -
Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice
Puranen, Jooseppi; Korhonen, Sonja; Haugas, Maarja; Lingasamy, Prakash; Teesalu, Tambet; Subrizi, Astrid; Urtti, Arto; Ruponen, Marika; Reinisalo, Mika. 2023. Journal of controlled release. 360: 810-817 -
Quantitative intravitreal pharmacokinetics in mouse as a step towards inter-species translation
Puranen, Jooseppi; Ranta, Veli-Pekka; Ruponen, Marika; Urtti, Arto; Sadeghi, Amir. 2023. Experimental eye research. 235: -
A Novel Ferroptosis Inhibitor UAMC-3203, a Potential Treatment for Corneal Epithelial Wound
Balla, Anusha; Tran, Bao; Valtari, Annika; Steven, Philipp; Scarpellini, Camilla; Augustyns, Koen; Urtti, Arto; Vellonen, Kati-Sisko; Ruponen, Marika. 2022. Pharmaceutics. 2023; 15: -
Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection
Puranen, Jooseppi; Koponen, Sanna; Nieminen, Tiina; Kanerva, Iiris; Kokki, Emmi; Toivanen, Pyry; Urtti, Arto; Ylä-Herttuala, Seppo; Ruponen, Marika. 2022. Experimental eye research. 224: -
Imaging, quantitation and kinetic modelling of intravitreal nanomaterials
Sadeghi, Amir; Ruponen, Marika; Puranen, Jooseppi; Cao, Shoupeng; Ridolfo, Roxane; Tavakoli, Shirin; Toropainen, Elisa; Lajunen, Tatu; Ranta, Veli-Pekka; van Hest, Jan; Urtti, Arto. 2022. International journal of pharmaceutics. 621: -
Improved ocular delivery of quercetin and resveratrol: A comparative study between binary and ternary cyclodextrin complexes
Krstić, Luna; Jarho, Pekka; Ruponen, Marika; Urtti, Arto; González-García, María J.; Diebold, Yolanda. 2022. International journal of pharmaceutics. 624: -
In-vitro dynamic dissolution/bioconversion/permeation of fosamprenavir using a novel tool with an artificial biomimetic permeation barrier and microdialysis-sampling
Eriksen, Jonas Borregaard; Christiansen, Jeppe Juhl; Bauer-Brandl, Annette; Ruponen, Marika; Rautio, Jarkko; Brandl, Martin. 2022. European journal of pharmaceutical sciences. 2023; 181: